Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESR1 Mutations in Metastatic Breast Cancer (FMER)
NCT02473120Completed
- Sponsor
- Centre Henri Becquerel
- Start
- Jun 2015
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Open-label trial in breast cancer, sponsored by Centre Henri Becquerel. Primary endpoint: Frequency of ESR1 mutations at 24 months. Started Jun 2015; status: completed.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02473120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473120.